Date: 27/05/2026 Where ADC Innovation Is Going: Multispecific & Multipayload Landscapes Unpacked View Article
Date: 21/05/2026 Fundamental properties and principal areas of focus in antibody-drug conjugates formulation development View Article
Date: 21/05/2026 Antibody-drug conjugates: Current challenges and innovative solutions for precision cancer therapy View Article
Date: 14/05/2026 Navigating Solid Tumor Heterogeneity: The Promise and Challenges of Antibody-Drug Conjugates View Article
Date: 14/05/2026 Monodisperse polysarcosine-based highly-loaded antibody-drug conjugates View Article
Date: 14/05/2026 First platinum(II)-based metal-organic linker technology (Lx®) for a plug-and-play development of antibody-drug conjugates (ADCs) View Article
Date: 14/05/2026 Impact of Maleimide Disubstitution on Chemical and Biological Characteristics of HER2 Antibody−Drug Conjugates View Article
Date: 14/05/2026 Novel development strategies and challenges for anti-Her2 antibody-drug conjugates View Article
Date: 14/05/2026 Enzymatic glycan remodeling–metal free click (GlycoConnect™) provides homogenous antibody-drug conjugates with improved stability and therapeutic index without sequence engineering View Article
